Thomas Stephan
Stock Analyst at Stifel
(1.39)
# 3,534
Out of 5,182 analysts
60
Total ratings
32.43%
Success rate
-8.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Maintains: Hold | $115 → $130 | $108.12 | +20.24% | 2 | Mar 9, 2026 | |
| OFIX Orthofix Medical | Maintains: Buy | $22 → $18 | $12.32 | +46.10% | 2 | Mar 9, 2026 | |
| ATEC Alphatec Holdings | Maintains: Buy | $24 → $20 | $10.36 | +93.05% | 3 | Mar 9, 2026 | |
| ALC Alcon | Maintains: Hold | $80 → $82 | $76.01 | +7.88% | 7 | Mar 9, 2026 | |
| STAA STAAR Surgical Company | Maintains: Hold | $19 → $18 | $26.68 | -32.53% | 12 | Mar 4, 2026 | |
| SGHT Sight Sciences | Maintains: Buy | $6 → $8 | $4.32 | +85.19% | 8 | Mar 2, 2026 | |
| GKOS Glaukos | Maintains: Buy | $115 → $160 | $122.07 | +31.07% | 10 | Jan 22, 2026 | |
| GMED Globus Medical | Reinstates: Hold | $64 | $93.70 | -31.70% | 1 | Oct 28, 2025 | |
| RXST RxSight | Maintains: Hold | $33 → $28 | $7.29 | +284.09% | 10 | Mar 19, 2025 | |
| BLCO Bausch + Lomb | Maintains: Hold | $19 → $18 | $15.88 | +13.35% | 3 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $2 | $1.08 | +85.19% | 2 | May 15, 2024 |
TransMedics Group
Mar 9, 2026
Maintains: Hold
Price Target: $115 → $130
Current: $108.12
Upside: +20.24%
Orthofix Medical
Mar 9, 2026
Maintains: Buy
Price Target: $22 → $18
Current: $12.32
Upside: +46.10%
Alphatec Holdings
Mar 9, 2026
Maintains: Buy
Price Target: $24 → $20
Current: $10.36
Upside: +93.05%
Alcon
Mar 9, 2026
Maintains: Hold
Price Target: $80 → $82
Current: $76.01
Upside: +7.88%
STAAR Surgical Company
Mar 4, 2026
Maintains: Hold
Price Target: $19 → $18
Current: $26.68
Upside: -32.53%
Sight Sciences
Mar 2, 2026
Maintains: Buy
Price Target: $6 → $8
Current: $4.32
Upside: +85.19%
Glaukos
Jan 22, 2026
Maintains: Buy
Price Target: $115 → $160
Current: $122.07
Upside: +31.07%
Globus Medical
Oct 28, 2025
Reinstates: Hold
Price Target: $64
Current: $93.70
Upside: -31.70%
RxSight
Mar 19, 2025
Maintains: Hold
Price Target: $33 → $28
Current: $7.29
Upside: +284.09%
Bausch + Lomb
Jan 29, 2025
Maintains: Hold
Price Target: $19 → $18
Current: $15.88
Upside: +13.35%
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $1.08
Upside: +85.19%